Multiple risk factors were associated with denials and longer wait times for biologic treatment in moderate to severe asthma, ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.

The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...

Adults taking the novel once-daily oral pill for plaque psoriasis had significantly higher rates of clear or almost clear ...

Greykasell Wealth Strategies Inc. acquired 708 shares of Regeneron Pharmaceuticals, valued at approximately $504,000. Other ...

Regeneron (REGN) faces a 3% stock drop after losing an appeals case over its Eylea drug patents against Amgen (AMGN).

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of ...

Attorney Stuart Silverman says the First Circuit’s widening the divide on the False Claims Act’s causation standard adds to ...

"One of the approaches I used in my project was bridging western medicine and also traditional indigenous practices." ...

A Pasadena resident is among the student winners of the prestigious Regeneron Science Talent Search, America's oldest science and math competition.

Celestial discoveries: Paz won the $250,000 top prize for his research on detecting objects in the night sky. Using ...